National Comprehensive Cancer Network

Subscriptions & Products
For Patients

About NCCN

Myelodysplastic Syndromes Panel - Disclosures as of 9/2/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Eyal Attar, MD

None

Celgene Corporation

None

None

12/4/2009

John M. Bennett, MD

None

Novartis Pharmaceuticals Corporation

None

Celgene Corporation;
Johnson & Johnson

1/22/2010

Clara D. Bloomfield, MD

None

None

None

None

9/28/2009

Carlos M. De Castro, MD

Celgene Corporation;
Cephalon, Inc.;
Pharmion Corporation

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Jannsen Pharmaceutica Products, LP;
Pharmion Corporation

None

None

7/7/2009

H. Joachim Deeg, MD

None

None

None

None

12/8/2009

James M. Foran, MD

Eisai Inc.;
Genzyme Corporation;
Medarex, Inc.

Celgene Corporation;
Sunesis Pharmaceuticals, Inc.

None

None

2/9/2010

Karin Gaensler, MD

       

Pending

Lauren Gallagher, RPh, PhD

None

None

None

None

8/23/2010

Guillermo Garcia-Manero, MD

Celgene Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

Merck & Co., Inc.;
MGI PHARMA, INC.;
Novartis Pharmaceuticals Corporation;
Pharmion Corporation

None

None

12/17/2009

Salil Goorha, MD

None

None

None

None

9/28/2009

Steven D. Gore, MD

Celgene Corporation;
Johnson & Johnson

Celgene Corporation

Celgene Corporation

None

12/8/2009

Peter L. Greenberg, MD

Amgen Inc.;
Celgene Corporation;
Eisai Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Onconova

Amgen Inc.;
Novartis Pharmaceuticals Corporation

None

None

4/23/2010

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

8/30/2010

David Head, MD

None

None

None

None

8/19/2009

Rami Komrokji, MD

Celgene Corporation;
Genentech, Inc.;
Array Biopharma;
Onconova

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

1/8/2010

Rashmi Kumar, PhD

None

None

None

None

7/15/2010

Lori J. Maness, MD

None

None

None

None

10/28/2009

Joan S. McClure, MS

None

None

None

None

7/18/2010

Michael M. Millenson, MD, FACP

None

Amgen Inc.;
Celgene Corporation;
GlaxoSmithKline

None

sanofi-aventis U.S.

12/8/2009

Stephen D. Nimer, MD

None

None

None

None

12/28/2009

Margaret R. O'Donnell, MD

National Cancer Institute

Anti-soma

None

None

5/24/2010

Mark A. Schroeder, MD

None

None

None

None

6/4/2010

Paul J. Shami, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

JSK Therapeutics Inc.

None

12/10/2009

Dorothy Shead, MS

None

None

None

None

7/18/2010

Richard M. Stone, MD

Novartis Pharmaceuticals Corporation

Celgene Corporation;
Cephalon, Inc.;
Genzyme Corporation;
Merck & Co., Inc.

None

None

2/9/2010

James E. Thompson, MD

None

None

None

None

4/28/2010

Peter Westervelt, MD, PhD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

10/6/2009

 

NCCN Website Supporters